Russell Investments Group’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$258K Hold
5,460
﹤0.01% 2576
2025
Q1
$213K Sell
5,460
-50,430
-90% -$1.97M ﹤0.01% 2571
2024
Q4
$3.03M Sell
55,890
-6,140
-10% -$332K ﹤0.01% 1436
2024
Q3
$3.13M Buy
62,030
+28,471
+85% +$1.44M ﹤0.01% 1449
2024
Q2
$1.48M Buy
+33,559
New +$1.48M ﹤0.01% 1789